Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

NCT00288743 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Critically Ill Patients

Interventions

DRUG: to implement an insulin protocol with target blood glucose levels between 81-110 mg/dL.

Sponsor

University Hospital, Ghent